General Information of the Compound
Compound ID
CP0325735
Compound Name
US8614253, 29-19
    Show/Hide
Synonyms
BDBM111359
CHEMBL3665044
SCHEMBL12674915
US8614253, 29-19
    Show/Hide
Structure
Formula
C20H17NO3
Molecular Weight
319.36
Canonical SMILES
CN(C)C(=O)c1cccc(c1)-c1ccc2c(C=O)c(O)ccc2c1
    Show/Hide
InChI
InChI=1S/C20H17NO3/c1-21(2)20(24)16-5-3-4-13(11-16)14-6-8-17-15(10-14)7-9-19(23)18(17)12-22/h3-12,23H,1-2H3
    Show/Hide
InChIKey
NWWPDKVVFKCCIV-UHFFFAOYSA-N
Physicochemical Property
logP
3.7267
Rotatable Bonds
3
Heavy Atom Count
24
Polar Areas
57.61
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
3
Complexity
24

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 59599768
ChEMBL ID
CHEMBL3665044
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02289, Serine/threonine-protein kinase/endoribonuclease IRE1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 3000 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 125 nM
Clinical Information about the Compound
Drug 1 ( US8614253, 29-19 )
Drug Name US8614253, 29-19
Target(s)
Endoplasmic reticulum to nucleus signaling 1 (ERN1)
Inhibitor